Maternal Epidural Steroids and Hyperthemia
- Conditions
- Complication of Anesthesia During Pregnancy, UnspecifiedFeverLabor Pain
- Interventions
- Drug: Normal saline
- Registration Number
- NCT02212210
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
The purpose of this study is to look to see if adding steroids to an epidural reduces the chances of having a fever in labor, and protects the baby from exposure to inflammation.
- Detailed Description
The association between epidural analgesia and increased maternal intrapartum temperature has been well documented in multiple randomized controlled trials. The exact mechanism for this elevation in temperature is unknown; however the most likely cause appears to be non-infectious inflammatory stimulation. Fetal exposure to maternal fever in utero has been linked with increased antibiotic treatment, increased neonatal sepsis evaluation, and longer length of stay for neonates. In addition there is evidence to suggest intrapartum fevers may lower the threshold for fetal hypoxic brain injury and increase the risk of cerebral palsy. The risk of neonatal encephalopathy in infants born to febrile mothers is 1% compared to 0.1% to afebrile mothers. Safe interventions are needed to prevent adverse fetal outcomes.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 135
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Normal saline Normal saline 2cc preservative free normal saline Methylprednisolone Methylprednisolone 1cc of 80mg methylprednisolone to be diluted with 1cc preservative free normal saline
- Primary Outcome Measures
Name Time Method Rate of maternal fever delivery Oral maternal temperature will be collected hourly starting at epidural placement. Temperature will be recorded until delivery.
- Secondary Outcome Measures
Name Time Method Rate of funisitis delivery Cord segment will be collected at time of delivery and fetal end identified and sent to pathologist for evidence of funisitis, grade and stage.
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States